Gnubiotics Sciences

company

About

Gnubiotics Sciences is a biotechnology company based in Switzerland.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
Fr787K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

GNUBiotics is developing a compound to reproduce the natural diversity and complexity of unique structures found in breast milk. These structures are beneficial in preventing infections and the onset of diet-induced obesity. It aims at feeding the microbiome.

In response to the rising demand for healthier foods they are developing functional and structural mimics of Human Milk Oligosaccharides, (HMOs) for the consumer health market. Their products reproduce the natural diversity and complexity of HMOs and have been shown to be beneficial in preventing the onset of gut infection and protect against the effect of antibiotic use.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr787K
Gnubiotics Sciences has raised a total of Fr787K in funding over 2 rounds. Their latest funding was raised on Jul 29, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 29, 2020 Debt Financing Fr787K 1 UBS Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gnubiotics Sciences is funded by 1 investors. UBS are the most recent investors.
Investor Name Lead Investor Funding Round
UBS Yes Debt Financing